Review
Oct 2026
Risk-stratified Prostate Cancer Screening in 2026: Blood- and Urine-based Biomarkers.
How blood and urine tests, alongside genetic risk information, can help identify the men most likely to harbor aggressive prostate cancer-enabling early detection and intervention while avoiding unnecessary biopsies and potential harm in men at low risk is discussed.
J. Stangl-Kremser, S. Salami
· European Urology Focus · 0 citations